New Releases: On-Demand Programs Produced by Dr Neil Love
Expert Second Opinion: The Optimal Management of HER2-Positive GI Cancers — Microlearning Activity 3
Practical Perspectives on the Management of Desmoid Tumors — Issue 2
Expert Second Opinion: Role of Immunotherapy and Targeted Therapy in the Management of Advanced GE Cancers — Microlearning Activity 2
Striving for Consensus — The Multidisciplinary Management of Nonmelanoma Skin Cancers: Cutaneous Squamous Cell and Basal Cell Carcinomas
Featuring case presentations by
Drs Jacqueline Brown and Nazli Dizman, with commentary from Dr Matthew Milowsky
Video EditionAudio Edition
Rapid Case Review: Investigators Provide Perspectives on Actual Cases of Metastatic Bladder Cancer — Issue 3
Second Opinion: Clinical Investigators Provide Perspectives on the Future Role of AKT Inhibition in the Management of Prostate Cancer
Diabetology for Medical Oncologists: Managing Hyperglycemia in Patients with Breast Cancer Receiving Agents Targeting PI3K/AKT/PTEN
Featuring perspectives from Drs Stacey Cohen, Christopher Lieu and Jenny Seligmann, moderated by Dr Lieu
Video EditionAudio Edition
Expert Second Opinion: The Use of Immunotherapy, MRD Assessment and Other Novel Approaches for Localized CRC — Microlearning Activity 1
Featuring perspectives from Drs Galsky, Gupta and Friedlander and Prof Necchi, moderated by Dr Friedlander
Video EditionAudio Edition
Second Opinion: Integrating Novel Approaches into the Management of Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer
Expert Second Opinion: Role of Immunotherapy and Targeted Therapy in the Management of Advanced GE Cancers — Microlearning Activity 1
Inside the Issue: CELMoDs for Multiple Myeloma — Microlearning Activity 1
Practical Perspectives on the Current and Future Management of ITP — What Happened at ASH 2025? Microlearning Activity 3
Featuring perspectives from
Dr Ellis, Prof Van Cutsem and Dr Wainberg, moderated by Dr Lionel A Kankeu Fonkoua
Video EditionAudio Edition
Expert Second Opinion: Investigators Discuss the Optimal Management of HER2-Positive GI Cancers — Microlearning Activity 2
| |
